Semaglutide

Introduction Semaglutide patent expiration date. The patent expiration of Semaglutide, the blockbuster GLP-1 agonist used for diabetes (Ozempic®) and obesity (Wegovy®), is set to reshape the pharmaceutical market. Developed by Novo Nordisk, this drug has generated billions in revenue—but its exclusivity period is nearing an end. This article explores:✔ When Semaglutide’s patents expire✔ How prices…

Semaglutide Wholesale Suppliers in 2025. The global semaglutide shortage has made finding trusted wholesale suppliers more challenging than ever. With counterfeit GLP-1 agonists flooding the market and Novo Nordisk struggling to meet demand, pharmacies, clinics, and distributors must navigate a high-risk supply chain. This guide reveals:✅ 5 verified wholesale channels (including hidden FDA-approved sources)✅ Red…